The Dawn of Molecular Medicine
The Transformation of Medicine and Its Consequences for Investors
May 27, 2011
The year is 2050. The location is a general hospital somewhere in the US. A baby is born, and a sample of her blood is taken for analysis, as is the norm for all newborns. The sample is sent to a molecular testing facility specializing in the analysis of genomes—the entirety of the hereditary information within us all. The complete genomic code of the baby is read, recorded and stored, and a computer program combs the billions of characters in the record of the baby’s genomic code, seeking any one of thousands of particular sequences. The matching sequences found reveal profound molecular information about the baby. In a matter of hours, a comprehensive molecular medical record is generated that indicates everything from her body’s likely response to particular drugs to her chances of developing various life-threatening diseases.